<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p145.xml</sm:loc>
    <ifp:title>Editorial</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p148.xml</sm:loc>
    <ifp:title>Breast Cancer Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p189.xml</sm:loc>
    <ifp:title>Decision-Making For Patients With Resectable Breast Cancer: Individualized Decisions For and By Patients and Their Physicians</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p199.xml</sm:loc>
    <ifp:title>Point: Sentinel Lymph Node Biopsy Is Indicated for Patients With DCIS</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p207.xml</sm:loc>
    <ifp:title>Counterpoint: Sentinel Lymph Node Biopsy Is Not Indicated for Ductal Carcinoma In Situ</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p215.xml</sm:loc>
    <ifp:title>The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p222.xml</sm:loc>
    <ifp:title>Taxanes in the Adjuvant Treatment of Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p232.xml</sm:loc>
    <ifp:title>The Role of Bisphosphonates in Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p242.xml</sm:loc>
    <ifp:title>Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p264.xml</sm:loc>
    <ifp:title>An Overview of Mammography: Benefits and Limitations</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p272.xml</sm:loc>
    <ifp:title>New Technologies in Breast Imaging</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p280.xml</sm:loc>
    <ifp:title>Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/1/2/article-p297.xml</sm:loc>
    <ifp:title>Breast Cancer Risk Assessment: A Guide for Clinicians Using the NCCN Breast Cancer Risk Reduction Guidelines</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
